Authors: | Milin Kurup OMS-II, Amit Agrawal MD, Sarah Temple MD, Sagar Galawankar MD |
Background: | As numerous studies have well documented, Traumatic Brain Injuries (TBI) are on the rise annually, attributed to motor vehicle accidents, falls, sports-related injuries, military combat, and numerous other orthopedic incidents. To counter the effects of TBI, scientists are continuing to improve point-of-care testing (POCT) involved in TBI diagnosis. Concussions and other less severe forms of TBI are often misdiagnosed or overlooked due to mild and often subtle symptoms. Currently, medical professionals utilize neuroimaging, cognitive scales, and biomarker assays to diagnose concussions and other forms of TBI. However, many of these parameters hinder diagnosis due to accessibility and time restraints. |
Purpose: | After specific analysis, it is clear there is a profuse amount of research surrounding time-sensitive concussion biomarker kinetics. This review aims to compile and analyze all published research on concussion POC biomarkers, screened between 2022-2023, in the National Institute of Health (NIH) National Library of Medicine PubMed Database. |
Description: | Commonly studied concussion POC biomarkers include Ubiquitin C-terminal hydrolase 1, Glial Fibrillary Acidic Protein, Visinin Like Protein-1, S100 calcium-binding protein B, tau, and Neurofilament Light chain. While these are the most studied, many other horizon biomarkers are still being tested, including immunological markers, genetic markers, and numerous other parameters. |
Conclusion | Each neurologic biomarker has its unique implications and limitations when characterizing TBI. Novel horizon biomarkers and multimodal paired concussion parameter models are continuously being evaluated for their respective diagnostic strengths and weaknesses. |
Key Words | Traumatic Brain Injuries (TBI), concussions, point of care (POC), point of care testing (POCT), biomarkers, Ubiquitin C-terminal hydrolase L1(UCHL-1), Visinin Like Protein-1 (VLP-1), S100 calcium-binding protein B (S100B), Glial Fibrillary Acidic Protein (GFAP), tau, Neurofilament Light chain (NfL), multimodal models |
This research was completed at Augusta University Department of Neuroscience and Regenerative Medicine
Authors: | Haley Bracy, OMS-II, Ferenc Deak, MD-PhD, Ankit Seth, MPharm-PhD |
Background: | Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by cognitive decline, with the main pathogenic hypothesis involving amyloid plaque buildup in the brain. Women are at a higher risk of developing AD than men with no definitive understanding of this disproportionate statistic. This project focused on amyloid beta accumulation in mice, utilizing a mouse line designed to mimic late onset AD. |
Purpose: | The research aimed to provide insight into how the buildup of Aβ impacts synaptic transmission rates, short-term memory, and anxiety-related behaviors, in the humanized amyloid beta knock-in (hAbeta-loxP-KI) mouse line and whether these effects differ between males and females. |
Description: | The study used a humanized Aβ knock-in mouse model to examine synaptic transmission using FM1-43 dye and high-potassium solutions to stimulate synaptic activity. Behavioral testing included open field and novel object tests to assess anxiety-related behavior and short-term memory. Male and female one-year-old mice were analyzed separately to compare sex-based differences in AD-related pathology. |
Conclusion: | Wild-type mice displayed faster synaptic transmission rates than male and female Aβ knock-in mice. Female Aβ knock-in mice displayed elevated anxiety-related behaviors and functioned at a diminished level in short-term memory tasks when compared to the males, suggesting that females may be more sensitive to Aβ accumulation. This supports the hypothesis that women may experience cognitive deficits from Aβ earlier than men when considering AD. The study provides valuable insights into sex-specific differences of late-onset AD, though future research with a larger sample size and more diverse age groups is necessary. |
Authors: | Hunter Turbyne OMS-II, Taylor Crue MPH, Leigha Larson BS , Lisa Spencer, PhD |
Background: | Eosinophilic esophagitis (EoE) is a chronic allergic condition characterized by eosinophil-driven inflammation and esophageal epithelial changes. It presents with dysphagia in adults and feeding difficulties in children. Recent studies suggest that Notch2, a regulator of eosinophil activity, plays a crucial role in eosinophil retention in the gastrointestinal tract during allergic responses. Notch2 deficiency in eosinophils impairs allergen-driven eosinophil accumulation in the gut without affecting eosinophils in the airway, indicating its selective role in gastrointestinal inflammation. |
Purpose: | This study aims to investigate the role of Notch2 signaling in eosinophilic inflammation and epithelial remodeling in eosinophilic esophagitis (EoE). The goal of the project is to evaluate the impact of Notch2 deficiency in eosinophils on key disease parameters, including eosinophil infiltration, eosinophilic abscess formation, and basal cell hyperplasia in esophageal epithelium. |
Description: | A chronic mouse model was used, where IL-5 overexpressing PL2-IL5 mice were treated with oxazolone (OXA) to develop esophageal epithelial changes resembling human EoE, including basal hyperplasia and eosinophilic abscesses due to Th2 cell activation. The PL2-IL5 mice were then crossed with eosinophilic Notch2 knockout (EoN2) mice to generate ENP5 mice, which overexpress IL-5 and lack Notch2 in eosinophils. Esophageal tissue from ENP5 and PL2-IL5 mice was stained with MBP and evaluated for eosinophil infiltration, eosinophilic abscesses, and basal cell hyperplasia using Ki67 staining. |
Conclusion: |
The study of the ENP5 mouse on basal cell hyperplasia and eosinophilic epithelial infiltration within the esophagus did not show significance in preventing EoE disease features. |
Authors: | Nicole Jadwiga Knight, OMS-II, Melinda Gevorgian, OMS-III, Julee Reitzel, OMS-III, and Lawrence L. LeClaire, III, PhD |
Background: | Dysregulation of kinase signaling is implicated in the uncontrolled growth and survival of cancer cells. Therefore, understanding the intricacies of these pathways is paramount for the development of targeted therapies. Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4), a member of the germinal center kinase (GCK) family, has been implicated in signaling pathways associated with cancer from cell division, migration, invasion, and adhesion. MAP4K4 is a single gene expressed as 55 differentially spliced variants across human tissues and may be involved in tissue specific signaling pathways. Here, we describe a PCR-based system to identify tissue splice variants of MAP4K4 from cell cultures. |
Purpose: | The purpose of this work is to identify MAP4K4 isozymes that are enriched in metastatic cells compared to normal epithelial cells using an inexpensive and rapid assay. |
Description: | Primer pair sets were designed to amplify coding sequences for internal control and variable MAP4K4 regions from human cell lines. These sets included: Primer set 1 (exons 2-11 kinase domain), Primers set 2 (citron homology domain); Primer set 3 (exons 13-17, 5 exons are alternatively spliced between poly-proline and arg/lys repeats); Primer set 4 (exons 18-20 - the interdomain). MAP4K4 regions were amplified from cDNA generated from RNA purified from normal (MCF-10A) and metastatic (MDA-MB-231) human breast cell cultures. Fragments were subcloned into plasmids and sequenced to identify isozymes. |
Conclusion: |
These primer sets were shown to amplify predicted products from cell cultures and will provide an assay to identify MAP4K4 isozymes from cell lines and isolated tissues. |
Authors: | William Dipprey, OMS-II*, Marc Erikson, OMS-II*, Nicole Jadwiga Knight, OMS-II, and Lawrence L. LeClaire, III, PhD |
Background: |
Dysregulation of kinase signaling is implicated in the uncontrolled growth and survival of cancer cells. Therefore, understanding the intricacies of these pathways is paramount for the development of targeted therapies. Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4), a member of the germinal center kinase (GCK) family, has been implicated in signaling pathways associated with cancer from cell division, migration, invasion, and adhesion. The kinase domain from MAP4K4 is a well-conserved domain shared across multiple genes in the GCK family from humans and found in many organisms from slime molds, yeasts, nematodes, and mammals.
|
Purpose: |
The purpose of this work was to amplify, sequence, and compare the kinase domain of MAP4K4 between normal and dysregulated epithelial cell cultures. Identification of ATP-binding domain(s) and comparison of sequence homologies will provide insight to kinase activity in cells. |
Description: |
Using the NIH Primer-BLAST tool, we designed multiple oligonucleotides to amplify the MAP4K4 kinase domain from dividing human breast cell cultures. The MAP4K4 kinase domain spans exons 2-11 of the single copy gene located at 2q11.2 in the human genome. These primers generated a 200 base pair product from cDNA generated from total RNA isolated from multiple human cell lines. These PCR products were subcloned, sequenced, and aligned to compare transcripts from normal and metastatic cells. |
Conclusions: |
We found that MAP4K4 sequences were conserved between both normal and metastatic cells. These data suggest that kinase activity is controlled by increased regulatory domain input or by increased expression levels of the gene. |
Authors: | Rachael Christensen, OMS-II, Nicole Jadwiga Knight, OMS-II, and Lawrence L. LeClaire, III, PhD |
Background: |
Metastatic breast cells require complex signaling to an array of regulatory proteins to control cell migration. The coordination of these signaling proteins is necessary to regulate the actin cytoskeleton and allow a metastatic cell to migrate from a primary tumor in response to growth factors. The microRNA miR-141-3p has been shown to regulate the expression of key signaling proteins responsible for cancer metastasis in several tissues, including the mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4). Here, we lay the groundwork to investigate the role of miR-141-3p on cell migration and invasion in established human breast cancer cell lines. |
Purpose: |
The purpose of this study was to compare mir141-3p and MAP4K4 RNA expression in metastatic breast cancer with normal breast cell cultures using quantitative PCR. |
Description: |
All quantitative PCR was performed from cDNA generated from RNA purified from normal (MCF-10A) and metastatic (MDA-MB-231) human breast cell cultures. We have found that consistently, MCF-10A cells express miR-141-3p at more than 30% that of MDA-MB-231 cells. Conversely, MAP4K4 gene expression is down-regulated in MCF-10A and increased in MDA-MB-231 cells. |
Conclusion: |
These data suggest that mir141-3p down-regulates MAP4K4 expression in normal epithelial cells through a regulatory domain in the upstream untranslated region of the MAP4K4 gene. Reduced expression of mir141-3p in MDA-MB-231 cells results in increased MAP4KA expression and thus increased levels of metastatic activity. Future studies aim to develop a liquid biopsy to identify microRNAs in patients for early detection of breast cancer. |
Authors: | Julia Kaufmann, OMS-II*, Carly Stuppiello, OMS-II*, Nicole Jadwiga Knight, OMS-II, and Lawrence L. LeClaire, III, PhD |
Background: |
Dysregulation of kinase signaling is implicated in the uncontrolled growth and survival of cancer cells. Therefore, understanding the intricacies of these pathways is paramount for the development of targeted therapies. Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4), a member of the germinal center kinase (GCK) family, has been implicated in signaling pathways associated with cancer from cell division, migration, invasion, and adhesion. The citron homology domain from MAP4K4 is a regulatory domain that contains multiple domains of unknown function that may contribute to kinase activity in metastatic cancer cells. |
Purpose: |
The purpose of this work was to amply, sequence, and compare the citron homology domain of MAP4K4 between normal and dysregulated breast cell cultures using a PCR-based screening tool developed by our research group. |
Description: |
Using the NIH Primer-BLAST tool, we designed multiple oligonucleotides to amplify the citron homology domain from MAP4K4 by PCR. The citron homology domain is C-terminal of the MAP4K4 kinase domain (exons 25-33) and includes an interdomain with three varying regions of interest: 1) a charged arg/lys domain, 2) a proline-rich domain, and 3) a ser/thr region. Each of these domains have potential for regulatory and structural functions. |
Conclusions: |
We found that our primer oligos amplified the citron homology domain. Sequence information was acquired and aligned with known MAP4K4 homologues to gain insight on domain function and metastatic activity. |
Authors: | Emily Adams, OMS-II, Elizabeth Steidley, OMS-II, Nicole Jadwiga Knight, OMS-II, and Lawrence L. LeClaire, III, PhD |
Background: | Dysregulation of kinase signaling is implicated in the uncontrolled growth and survival of cancer cells. Therefore, understanding the intricacies of these pathways is paramount for the development of targeted therapies. Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4), a member of the germinal center kinase (GCK) family, has been implicated in signaling pathways associated with cancer from cell division, migration, invasion, and adhesion. Like most kinases of the GCK family, MAP4K4 activity is modulated by binding to an interdomain sequence of amino acids on the C-terminal region of the protein. Alternative splicing of the interdomain or mutations may lead to upregulation of the kinase and increased motility of metastatic cells. |
Purpose: | The purpose of this work was to amply, sequence, and compare the interdomain of the MAP4K4 and compare alternative spliced transcripts between normal and dysregulated breast cell cultures using a PCR-based screening tool developed by our research group. |
Description: | Using the NIH Primer-BLAST tool, we designed multiple oligonucleotides to amplify the MAP4K4 interdomain from human breast cell cultures. These primers generated a 300-base pair product from cDNA made from RNA isolated from multiple human cell lines. PCR products were subcloned, sequenced, and aligned to compare transcripts from normal and metastatic cells. |
Conclusion: |
Nucleotide sequences from both normal and metastatic cells were compared from multiple cell lines and identified three potential binding sides for autoregulation of the MAP4K4 kinase domain. Variations in exon splicing or mutations found in metastatic cells could explain increased metastatic activity observed in cell cultures. |
Authors: | Jessica Hecker OMS-II, Rhett Layton OMS-II |
Abstract: |
This case study investigates the risks of high folic acid supplementation in expecting mothers, with a focus on those with the methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism. While folic acid is vital for DNA synthesis and preventing neural tube defects, excessive intake may pose health risks, especially for those with the MTHFR variant. These individuals have reduced folic acid processing ability, leading to unmetabolized folic acid (UMFA) accumulation, which is linked to vitamin B12 deficiency, cognitive and psychiatric issues, and adverse pregnancy outcomes. The study highlights the need for careful monitoring of folic acid intake and explores alternative supplements like 5-MTHF or 5-FTHF that may mitigate these risks by bypassing MTHFR conversion. Personalized nutrition considering genetic variations is crucial for optimizing health and avoiding potential harm. |
Authors: |
Hannah Berko OMS-II, Isabella Porter OMS-III, Benford Mafuvadze PhD, MVSc, BVSc |
Background: | Progestins have been found to alter microRNA expression in cancer and different tissues in humans, potentially contributing to breast cancer progression and metastasis. Various progestins regulate specific microRNAs that influence genes essential to hormone-responsive breast cancer growth and development. Computer analysis identified pri-miR-190 and pri-miR-199a-1 as potential targets for CD44 and VEGF, proteins that promote tumor proliferation and angiogenesis. This study aimed to determine the effect of progestins on transcriptional expression of pri-miR-190 and pri-miR-199a-1 in PR-expressing T47D breast cancer cells. |
Methods: | We exposed T47D breast cancer cells to the natural hormone, progesterone, and three synthetic progestins, medroxyprogesterone acetate (MPA), norgesterol, and norethindrone. RNA was extracted after 24 hours of exposure and real-time PCR was conducted to determine the transcriptional expression of pri-miR-190 and pri-miR-199a-1. T47Dco-Y, a negative progesterone receptor (PR) cell line was also tested to further confirm the role of PR-dependent pathways on expression of the tested microRNAs. |
Results: | Results showed significantly increased transcriptional expression of pri-miR-190 and pri-miR-199a-1 in T47D breast cancer cells when exposed to progesterone and synthetic progestins. RU-486, a PR antagonist, suppressed induction of progestins in pri-miR-190 and pri-miR-199a-1. A PR-negative T47D cell line did not yield any progestin induced effects, indicating involvement of PR-dependent pathways. T47D cells exposed to 17β estradiol had no transcriptional increase of pri-miR-190 and pri-miR-199a-1, suggesting exclusivity to progestins. |
Conclusion: |
Natural and synthetic progestins increase transcriptional expression of pri-miR-190 and pri-miR-199a-1 through processes directly dependent on the progesterone receptor. Both microRNAs tested can be potential biomarkers in progesterone receptor positive breast cancers. |
Authors: | Andrea Shammas MS, OMS-II, Michel Baudry Ph.D |
Abstract: |
The early postnatal period is a valuable model for studying synaptic plasticity, as pyramidal neurons and interneurons adjust their numbers to balance levels of excitation and inhibition. A recent study found that NMDA receptors and calpain-1 work together to maintain neuronal survival during this time, but it did not specify which neuron types were protected. This study investigated the level of cell death in both excitatory and inhibitory neurons in wild-type (WT) and calpain-1KO (C1KO) mice at postnatal day 7. We hypothesized that during the critical period, calpain-1 plays an integral role in neuronal survival. In addition, Calpain-1 exists as a homeostatic mechanism that maintains the balance between excitation and inhibition in the tri-synaptic circuit of the hippocampus, which would result in a similar fraction of degenerating pyramidal and inhibitory neurons. This project used co-staining techniques to visualize and quantify excitatory and inhibitory neuronal apoptosis levels in the hippocampus of WT and C1KO mice. The results showed increased apoptosis of both excitatory and inhibitory neurons in C1KO mice, with a higher percentage of apoptotic inhibitory neurons. In the tri-synaptic circuit of the hippocampus, interneuron apoptosis was significantly increased in the CA1 and dentate gyrus regions. These findings suggest that calpain-1 serves as a homeostatic mediator of excitation and inhibition in mouse brains and highlights its distribution in the hippocampus. Overall, the study demonstrates that calpain-1 activity prevents neuronal apoptosis in the mouse hippocampus and offers insights into early synaptic plasticity. |
Authors: |
A. Kuzema, B, M.O. Ibiwoye, MD, MS, DTM&H, MPH, PhD, J. Lyons, MD and J.D. Foster, PhD, HHRT |
Authors: | Unika Mirza, OMS-II Dr. Eric Johnson, PhD |
Background: |
This project sought to find associated phenotypic abnormalities correlating to mutations within the Glucokinase Regulatory Protein (GKRP). GKRP will modulate the body’s reaction to different levels of glucose in the blood which has clinical implications of hyperglycemia or hypertriglyceridemia depending on the genotype of the GKRP. This project aimed to characterize different genetic variants of GKRP through analysis of its enzymatic activity and how it compared to the native GKRP. |
Design: | This project utilized an in vitro assay which was designed and validated. Each mutation was tested utilizing E. coli produced and purified recombinant protein. The resulting protein Vmax was compared in order to analyze the activity of the mutational enzyme against the native GKRP. Comparing the Vmax helped to decipher what kind of activity the mutation has compared to the native GKRP. |
Results: | A known pathogenic variant P446L was compared to the native protein and its activity was compared with the findings from other peer reviewed articles which came to the similar conclusion that it was pathogenic. An additional variant, Q443R was also tested for pathogenicity. Results concluded that their activity levels were decreased with this mutation. |
Conclusion: | Results showed that the activity of the P446L and Q443R mutations decreased the activity of the glucokinase regulatory protein enzyme leading to clinical implications of hyperglycemia. Some limitations with this research are that it did not investigate other factors which may affect the way a protein mutation affects the human body. |
Authors: | Kunal Patel OMS-II, Dr. Eric Johnson PhD |
Background: | This project aimed to identify phenotypic abnormalities associated with mutations in the Glucokinase Regulatory Protein (GKRP). Glucokinase Regulatory Protein (GKRP) plays a key role in regulating the body’s response to varying glucose levels in the bloodstream. Its activity is clinically significant in conditions such as hyperglycemia and hypertriglyceridemia, depending on how active the GKRP is. The objective of this project was to study two genetic variants of GKRP through in vitro analysis, examining their enzymatic activity and comparing them to the native form of the protein. |
Design: | Both mutations utilized an in vitro inducted into E. coli, purified, confirmed with SDS Page, and an assay was conducted to obtain the Vmax of the mutation and analyze its activity. The Vmax activity was compared to the native variant protein Vmax and it was determined from there what kind of activity the mutation displayed. |
Results: | Two variants, I500S, and G107V, were tested for their enzymatic activity. Results showed that the enzymatic activity of GKRP was decreased with both genetic mutations. |
Conclusion: |
The Vmax values were decreased in both of the genetic mutations. This can lead to hyperglycemia and subsequent diabetes in patients with these genetic mutations. Some limitations to this project could be that the assay was not sensitive enough to change within the protein activity. |